Sign up for free insights newsletter
AY

ARTRYA Ltd

AYAAustralian Securities Exchange

Need professional-grade analysis? Visit stockanalysis.com

A$2.70
+0.75%
End of day
Market Cap

$484.97M

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.72-1.10-1.510.964.820.201.07
Calmar-8.04-3.53-1.881.085.130.140.50
Sharpe-0.68-0.81-1.170.642.670.120.54
Omega0.060.800.641.161.371.121.03
Martin-10.11-8.13-2.972.3112.610.191.90
Ulcer9.8810.1929.8321.9819.1964.2731.25

ARTRYA Ltd (AYA) Price Performance

ARTRYA Ltd (AYA) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at AUD2.70, up 0.75% from the previous close.

Over the past year, AYA has traded between a low of AUD0.57 and a high of AUD5.07. The stock has gained 229.3% over this period. It is currently 46.7% below its 52-week high.

ARTRYA Ltd has a market capitalization of $484.97M.

About ARTRYA Ltd

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Company Info

Exchange
Australian Securities Exchange
Currency
AUD
Country
Australia

Financial Metrics

Revenue (TTM)
$29,000
EBITDA
$-21,044,000
Profit Margin
-58592.85%
EPS (TTM)
-0.17
Book Value
0.56

Technical Indicators

52 Week High
A$5.24
52 Week Low
A$0.56
50 Day MA
A$3.60
200 Day MA
A$2.68
Beta
0.51

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
16723.15
Price/Book
5.46
Enterprise Value
$411.92M